Maze Therapeutics, Inc.
(MAZE - NASDAQ)
26,21 USD
📋 Profilo Aziendale

Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidney and metabolic diseases in the United States.

|